Press / Media
- 1 results
Search results
-
US Patent Issued to The Board of Regents of The University of Texas System on April 28 for "EPAC1 activators as HIV latency reversal agents (LRA)" (Texas Inventors)
4/29/20
1 item of Media coverage
Press/Media: Expert Comment